<DOC>
	<DOCNO>NCT02749123</DOCNO>
	<brief_summary>A comparison transdermal patch efficacy , side effect quality life patient back pain arthritis . The three arm trial ; prescription strength lidocaine 5 % , counter lidocaine 3.6 % , menthol 1.25 % placebo .</brief_summary>
	<brief_title>Comparison Prescription Lidocaine Patch Over Counter Lidocaine Patch Placebo Back Pain Arthritis</brief_title>
	<detailed_description>In comparison ; lidocaine 5 % , lidocaine/menthol 1.25 % placebo patient back pain arthritis , subject qualify meeting various inclusion exclusion criterion . Subjects sign informed consent randomize double blind fashion one three arm . After randomization subject complete baseline questionnaire regard pain affect live . Then begin therapy blind product . This questionnaire administer second day therapy final day day 10 . Responses day two ten endpoint compare baseline access response arm .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>Diagnosis back pain Diagnosis arthritis Pregnancy expect pregnancy next three month Allergic lidocaine , menthol methylparaben No reliable access internet Baseline average pain intensity 1,2,9 10 scale 0to 10 . Pain area body conducive patch therapy ( eg finger , toe etc )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>